is semaglutide a controlled substance FBI warns about counterfeit weight loss drugs Semaglutide | C187H291N45O59 | CID

Lillys Mounjaro, whose main ingredient is tirzepatide, was approved by the FDA in 2022 to treat diabetes, though it has also been used for weight loss

Quitting tobacco: Avoid tobacco products and even exposure to secondhand smoke

GLP-1 Drugs and Shifting Consumer Behavior

Active pancreatitis or a history of pancreatitis is a contraindication

"Retatrutide, a GIP, GLP-1, and glucagon receptor agonist for obesity: A phase 2 trial." New England Journal of Medicine , 389(6), 514-526

Summary: During your first week on GLP-1 medications, you can expect reduced appetite, gastrointestinal side effects such as nausea and bloating, and possible modest weight changes as your body adjusts to the treatment